Due to the promise and success of biobanking and translational medicine, millions of people with a variety of conditions will someday be able to access better treatments that will improve their prognoses and quality of life. However, a smaller but prevalent number may be unable to experience these benefits due to reactions or resistance to certain drugs. Because of this, the Mayo Clinic is collaborating with Baylor College of Medicine to study 10,000 of the donors in their freezer inventory to check for these potential problems. Researchers plan to sequence the DNA of these patients for 69 different genes that can influence metabolization and reactions to different medicines, a project that could improve both treatment protocols and biorepository management.
Continue reading “Mayo Clinic Plans New Study to Investigate Genetic Cause of Drug Reactions and Resistance”